Shobha Silva

7 Assessing melanoma BRAF status through ddPCR of cfDNA

A. Cox, I. Brock, S. Danson, 2019, Postgraduate Medical Journal.

HER2-enriched subtype and novel molecular subgroups drive aromatase inhibitor resistance and an increased risk of relapse in early ER+/HER2+ breast cancer

M. Dowsett, M. Cheang, D. Rea, 2022, EBioMedicine.

The DANTE trial protocol: a randomised phase III trial to evaluate the Duration of ANti-PD-1 monoclonal antibody Treatment in patients with metastatic mElanoma

R. Plummer, F. Gallagher, J. Bestall, 2021, BMC cancer.

Targeted therapy and new anticancer drugs in advanced disease.

S. Danson, Shobha Silva, S. Silva, 2013, Thoracic surgery clinics.

Bone-targeted agents in the treatment of lung cancer

P. Woll, Caroline Wilson, Shobha Silva, 2015, Therapeutic advances in medical oncology.